Mangione-Smith R, O'Leary J, McGlynn E A
Department of Pediatrics, University of California, Los Angeles 90095-1752, USA.
Sex Transm Dis. 1999 Jul;26(6):309-16. doi: 10.1097/00007435-199907000-00001.
The Health Plan Employer Data and Information Set (HEDIS) is a set of performance measures used to assess the quality of care delivered in managed care plans. New measures that address unevaluated areas of care are continuously being developed. Chlamydia screening among young women is one new measure that was recently adopted by the National Committee for Quality Assurance (NCQA) for inclusion in HEDIS. An essential criterion for new measures is that the clinical intervention is beneficial to health and cost-effective.
To assess the health benefits and cost-effectiveness of chlamydia screening among young women.
A focused review of the literature was performed using Medline. Articles addressing the epidemiology of chlamydia infection, its health consequences, and the benefits, problems, and cost-effectiveness associated with chlamydia screening are reviewed.
The literature reviewed shows scientific and cost-effectiveness data that support the adoption of the HEDIS measure for chlamydia screening among young women.
The National Committee for Quality Assurance's recent adoption of the measure for chlamydia screening among young women into the formal HEDIS measurement set is justifiable from a health benefit standpoint and from a cost-effectiveness standpoint.
健康计划雇主数据与信息集（HEDIS）是一组用于评估管理式医疗计划中所提供医疗服务质量的绩效指标。针对未评估的医疗领域的新指标在不断开发中。年轻女性衣原体筛查是一项新指标，最近被国家质量保证委员会（NCQA）采纳纳入HEDIS。新指标的一个基本标准是临床干预对健康有益且具有成本效益。
评估年轻女性衣原体筛查的健康益处和成本效益。
使用Medline对文献进行了重点综述。对涉及衣原体感染的流行病学、其健康后果以及与衣原体筛查相关的益处、问题和成本效益的文章进行了综述。
所综述的文献显示了科学和成本效益数据，支持在年轻女性中采用HEDIS衣原体筛查指标。
从健康益处角度和成本效益角度来看，国家质量保证委员会最近将年轻女性衣原体筛查指标纳入正式的HEDIS测量集是合理的。
